Strategic partnerships GraphiteRx is actively forming and highlighting partnerships with industry players like Bluesight and Cost Plus Drugs, signaling a collaborative momentum that can open co-sell opportunities, data integration deals, and expanded marketplace reach for your solutions.

Marketplace expansion With three solution lines including provider, supplier, and marketplace offerings, GraphiteRx demonstrates a scalable platform ready for multi-segment penetration, suggesting upsell opportunities from providers to marketplace access and from suppliers to integrated e-commerce and compliance tools.

Compliance and 340B leverage A strong emphasis on compliance and 340B management via GraphiteOM presents a compelling entry point for conversations with hospitals and health systems seeking audit-ready procurement, cost controls, and streamlined reporting.

AI and security focus Powered by AI with enterprise-grade security and cloud-native deployment, GraphiteRx targets healthcare organizations prioritizing intelligent workflows and data protection, offering a platform-ready rationale for competitive differentiation and rapid ROI.

Financial and market potential Current revenue tier and recent funding indicate growing traction and a favorable funding environment, presenting an opportune moment for value-based pitches around cost reduction, transparency, and faster time-to-value in pharmaceutical supply chains.